What would you like to do on
Pharma IQ today?
Upcoming
Webinars
Latest
Events
Become
a Member
Advertise
with Us

What would you like to do on Pharma IQ today?

Upcoming
Webinars
Latest
Events
Become
a Member
Advertise
with Us

LATEST CONTENT

In Silico Tools in Predictive Toxicology at Merck KGaA- An Interview with Philip Hewitt  

In silico tools are becoming increasingly important in predicting compounds which will have detrimental effects on areas like hERG binding and... Learn more »
October 31,2014 by Philip Hewitt 

2015 Pharma Outsourcing & Procurement Survey  

We are asking for your perceptions and experiences of outsourcing and procurement in the pharmaceutical industry. Take part in the biggest survey of... Learn more »
October 30,2014 by Pharma IQ Surveys 

Compliance in Your Distribution Plan  

Clinical Trial Supply is an environment where what is produced is very expensive. The time criticality is paramount. Delays due to compliance are... Learn more »
October 28,2014 by Justine Swinney 

UPCOMING EVENTS

UPCOMING WEBINARS

  • RBC’s Epigenetics Toolbox: Enabling Epigenetic Research and Drug Discovery Register now »
  • Translational Medicine Informatics - A Biopharma Case Study Watch now »
  • Product Inspection in the Packaging Industry - Are You Ready? Watch now »
  • How do You Maintain a Low Risk Global Supply of Drug Delivery Products in an Ever Changing and Uncertain World? Watch now »
  • Don't Let Geopolitical Developments in Eastern Europe Derail Your Clinical Trials - Applying Local Knowledge Watch now »

LATEST WHITE PAPERS

Predictive Toxicology eBook: Insights from Industry & Research  

Late stage drug attrition costs pharma as much as $1 billion per successful drug. This is a problem which requires new approaches from both industry and research and closer collaboration between the two. In this 21 page eBook, Pharma IQ brings you insights from key thought leaders from academia and industry into predictive toxicology. Within these six expert interviews there are industry case studies on reducing animal model usage, novel technologies being applied, new models developed and insights into the trends which will be driving this area in the coming years. Read more »
October 27,2014

The Future of Clinical Trial Supply – Trends and Challenges 2015 Report  

To discover the driving trends and priorities in clinical trial supply, Pharma IQ recently conducted the Clinical Trial Supply Outlook Survey 2015. This collected information and opinions from a diverse array of clinical trials professionals to take the pulse of this changing area. In this report, we gather these responses as well as expert insight on the findings along with interviews with thought leaders and articles on key trends to give you an in depth look at the current state of clinical trial supply Read more »
October 14,2014

The Antidote - Taking a Look at Corporate Inversions and e-Health  

Summer is at an end and whilst corporate activity continued apace, including AbbVie acquiring Shire, Omega Pharma attracting acquisition interest, and GSK and Sanofi seeking to dispose of certain of their older drugs, some of you have been cooling off with the ALS Ice Bucket Challenge! This icy event not only brought attention to this rare disease, but highlighted that the drug development pipeline for ALS needed to be bolstered, and reminded us of the high level of costs associated with drug development, particularly if a drug fails. Let’s see whether this innovative, albeit chilly, approach to raise awareness encourages more companies to look to drug development. Read more »
October 10,2014

LATEST INTERVIEWS

In Silico Tools in Predictive Toxicology at Merck KGaA- An Interview with Philip Hewitt  

In silico tools are becoming increasingly important in predicting compounds which will have detrimental effects on areas like hERG binding and genotox, but we need better predictability of complex effects such as hepatotoxicity or CNS effects. In this interview Philip Hewitt, Early Non-Clinical Safety (Liver and Kidney) at Merck KGaA describes how safety and predictive toxicology is carried out at Merck KGaA and what changes he predicts for the field in the coming years Read more »
October 31,2014 by Philip Hewitt 

Compliance in Your Distribution Plan  

Clinical Trial Supply is an environment where what is produced is very expensive. The time criticality is paramount. Delays due to compliance are extremely costly but entirely avoidable. In this interview Justine Swinney, Managing Partner at Brizzey LLC lays out the key elements to ingraining compliance in your distribution plan. Read more »
October 28,2014 by Justine Swinney 

Working Effectively with a CRO  

In this Pharma IQ interview Helle Aagaard-Kirkeby Primary Clinical Supply Manager, Clinical Supply Development, Lundbeck speaks to Pharma IQ about the key challenges that companies are facing in clinical trial supply and how to overcome them. Aagaard-Kirkeby shares her insights on the keys to choosing the right CRO and how to maintain the best working relationship. Read more »
October 23,2014 by Helle Aagaard-Kirkeby 

LATEST PODCASTS

Utilising Big Data for Bioscience Product Development  

Big data is turning up everywhere. In this Process Perspectives podcast, Kaare Buch Petersen, Information Architect in Global IT at Christen Hansen, a Denmark-based supplier of bioscience products to food and health industries, talks about how his company has been using big data in the development of their new products. Learn more »
July 03,2014

Fewer Robots, More Apps - An Interview with Jeff Hurst  

The informatics landscape is changing quickly and innovation could be the key to increasing efficiency. Jeff Hurst talks us through these changes and how the industry is moving away from robots towards more innovative methods including mobile apps. He also talks about the dangers of becoming overly 'enamoured with your data' and reinforces that the old rule Garbage in - Garbage Out still applies. Learn more »
March 25,2014

What Pharma can Learn from the Food & Beverage Industry- An Interview with Pepsico's Steve Hills  

The pharma industry has a lot to learn from the food and beverage industry when it comes to contract manufacturing. To get to grips with this outsider's view, we spoke with Steve Hills, European Contract Manufacturing Director at Pepsico. Steve outlines where companies can go wrong in working with CMOs Learn more »
March 13,2014

B2B Latest Events

Get the latest Pharma IQ news and Updates

Connect with your peers
Already a member? Sign In to complete your profile or Become a Member today!


Advertise With Us

Join the Pharmas IQ Community